Merck & Co Inc., pharmaceutical giant who manufactured Fosamax, has agreed to pay $27.7 million to approximately 1,200 plaintiffs to resolve claims that their drug used to treat osteoporosis caused the bones in their jaws to deteriorate.
The...
Merck & Co Inc., pharmaceutical giant who manufactured Fosamax, has agreed to pay $27.7 million to approximately 1,200 plaintiffs to resolve claims that their drug used to treat osteoporosis caused the bones in their jaws to deteriorate.
The...
What are some of the risks associated with Fosamax?
There are a variety of serious risks associated with Fosamax. While Fosamax has proven to be an effective treatment for bone thinning disorders such as osteoporosis, it has...
Generically known as alendronic acide or alendronate sodium, Fosamax is a bisphosphonate tablet prescribed in the treatment of osteoporosis, particularly in postmenopausal women. Fosamax has been proven effective at preventing...